期刊文献+

中药内服联合激素吸入治疗支气管哮喘缓解期肺脾气虚证患儿Meta分析 被引量:1

Meta-Analysis on Oral Administration of Chinese Herbal Medicine Combined with Hormone Inhalation for Children with Bronchial Asthma in Remission Stage with Lung-Spleen Qi Deficiency Syndrome
下载PDF
导出
摘要 目的:利用数据挖掘的方法验证中药内服联合激素吸入治疗支气管哮喘缓解期肺脾气虚证患儿的疗效。方法:收集已发表的关于中药联合激素(试验组)对比激素(对照组)治疗支气管哮喘缓解期肺脾气虚证患儿的临床文献,筛选后运用RevMan 5.3软件对2组有效率、总症状积分、第1秒用力呼气容积(FEV1)、哮喘发作次数进行Meta分析。结果:共纳入17个临床随机对照试验,1 569例患者。Meta分析结果显示,与对照组比较,试验组患者临床总有效率较高,哮喘发作次数及总症状积分较低,差异均有统计学意义(P<0.05);FEV1较高,但差异无统计学意义。结论:对于支气管哮喘缓解期肺脾气虚证的患儿,中药内服联合激素吸入较单纯吸入激素效果更佳。 Objective: To verify the curative effect of oral administration of Chinese herbal medicine combined with hormone inhalation for children with bronchial asthma in remission stage with lung-spleen qi deficiency syndrome by the method of data mining. Methods:Published clinical literature on treating children with bronchial asthma in remission stage with lung-spleen qi deficiency syndrome were selected, in which the experiment group treated with Chinese herbal medicine combined with hormone and the control group treated with hormone were compared. After screening, Metaanalysis on the effective rates,total symptom scores,the forced expiratory volume in one second(FEV1) and the numbers of asthma attacks in the two groups was conducted by RevMan 5.3 software. Results: A total of 17 clinical randomized controlled trials were included,with 1 569 cases of patients. Meta-analysis results showed that when compared with those in the control group,the total clinical effective rate in the experiment group was higher and the number of asthma attacks as well as the total symptom scores were lower,differences being significant(P<0.05);FEV1 was higher,but there was no significance in the difference. Conclusion: For the children with bronchial asthma in remission stage with lung-spleen qi deficiency syndrome,the therapy of oral administration of Chinese herbal medicine combined with hormone inhalation has better effect than that of inhaling hormone alone.
作者 寇晓华 陈慧 李雯雯 KOU Xiaohua;CHEN Hui;LI Wenwen
出处 《新中医》 CAS 2020年第17期13-16,共4页 New Chinese Medicine
基金 天津市卫生计生行业高层次人才选拔培养工程建设项目(津人才[2017]18号)。
关键词 支气管哮喘缓解期 肺脾气虚证 激素吸入 中药内服 META分析 Bronchial asthma in remission stage Lung-spleen qi deficiency syndrome Hormone inhalation Oral administration of Chinese herbal medicine Meta-analysis
  • 相关文献

参考文献15

二级参考文献98

  • 1杜永成,许建英,秦芳,韩葆芬.黄芪对致敏大鼠气道壁转化生长因子β_1、Ⅲ型胶原和纤维连接蛋白表达的影响[J].中国中西医结合杂志,2005,25(S1):29-32. 被引量:4
  • 2黄文哲,柳燕,秦民坚,窦昌贵.太子参提取物对小鼠免疫功能的影响[J].现代中药研究与实践,2005,19(6):35-37. 被引量:35
  • 3沈华浩,应英华.新版全球哮喘防治创议(GINA)方案的评价和解读[J].临床内科杂志,2007,24(4):221-223. 被引量:44
  • 4中华医学会儿科学分会呼吸学组.儿童支气管哮喘诊断与防治指南.中华儿科杂志,2008,.
  • 5中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:54-58.
  • 6中华人民共和国卫生部主编.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:127-128.
  • 7汪受传,虞坚尔.中医儿科学[M].北京:中国中医药出版社,2012:84-90.
  • 8中华中医药学会.中医儿科常见病诊疗指南[M].北京:中国中医药出版社,2012:17-21.
  • 9Masoli M, Fabian D, Holt S, et al. The global burden of asthma: executive summary of the GINA Dissemination Committee Report. Allergy, 2004, 59:469-478.
  • 10Global Initiative for Asthma. Pocket guide for asthma management and prevention [ EB/OL]. (2012-12) [ 2013-05-25 ]. http:// www. ginasthma, org/local/uploads/files/GINA _ Pocket2013 _ MaylS. pdf.

共引文献1706

同被引文献22

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部